BioCryst Pharmaceuticals
BCRX
BCRX
103 hedge funds and large institutions have $501M invested in BioCryst Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 36 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
–
Holders Change %
0%
% of All Funds
2.36%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
25
Reduced
36
Closed
10
Calls
$972K
Puts
$484K
Net Calls
+$488K
Net Calls Change
+$31K
Top Buyers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$63.6M |
| 2 |
2
D.E. Shaw & Co
New York
|
$9.36M |
| 3 |
3
BlackRock
New York
|
$44.4M |
| 4 |
VMI
4
VHCP Management II
New York
|
$14.1M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$5.75M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AG
101
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
FHA
102
Flagship Harbor Advisors
Boston,
Massachusetts
| $1K | +$1K | +300 | New |
|
|
AA
103
ALPS Advisors
Denver,
Colorado
| – | -$630K | -132,021 | Closed |
|
|
FDCDDQ
104
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$207K | -43,502 | Closed |
|
105
AQR Capital Management
Greenwich,
Connecticut
| – | -$139K | -29,043 | Closed |
|
|
OAM
106
Oberweis Asset Management
Lisle,
Illinois
| – | -$114K | -24,000 | Closed |
|
107
Creative Planning
Overland Park,
Kansas
| – | -$88K | -18,350 | Closed |
|
108
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$78K | -16,253 | Closed |
|
|
VF
109
Virtu Financial
New York
| – | -$54K | -11,374 | Closed |
|
|
AF
110
Allworth Financial
Folsom,
California
| – | -$2K | -500 | Closed |
|
|
KF
111
Krilogy Financial
St. Louis,
Missouri
| – | -$1K | -200 | Closed |
|